Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Authors

  • Ugyen Zangmo Jigme Dorji Wangchuk National Referral Hospital, Thimphu, Bhutan
  • Sushma Jayanna Shantilal Shanghvi Eye Institute, Mumbai, India https://orcid.org/0000-0002-4020-2147
  • Mahesh P Shanmugam Sankara Eye Foundation, Bangalore, India

DOI:

https://doi.org/10.3126/nepjoph.v15i2.55033

Keywords:

avastin, failed macular hole closure, secondary macular hole

Abstract

Background: Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.

Case: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.

Observations: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention. 

Conclusion: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.

Downloads

Download data is not yet available.
Abstract
71
PDF
70
Cover NepJOPH

Downloads

Published

2023-12-31

How to Cite

Zangmo, U., Jayanna, S., & Shanmugam, M. P. (2023). Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation. Nepalese Journal of Ophthalmology, 15(2), 97–101. https://doi.org/10.3126/nepjoph.v15i2.55033

Issue

Vol. 15 No. 2 (2023)

Section

Case Reports

License

Copyright (c) 2023 Nepalese Journal of Ophthalmology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.